王宗仁(Wang, Tsung-Jen) 教授

Email
tjw@tmu.edu.tw
現   職
眼科學科 主任
眼科學科 教授

學經歷

學 歷

畢業學校與學位[修業時間]
國立臺灣大學臨床醫學研究所 碩士
2006/09~2008/06
國立臺灣大學醫學系 學士
1995/07~2001/06

本校學術經歷

任職單位與職稱[起迄時間]
眼科學科教授
2022/08/01~
眼科學科副教授
2017/02/01~2022/07/31
眼科學科助理教授
2012/08/01~2017/01/31
眼科學科講師
2012/02/01~2012/07/31

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
眼科學科主任
2020/08/01 ~

其它經歷

任職單位與職稱[起迄時間]
臺北醫學大學附設醫院眼科主治醫師
臺大醫院住院醫師
2001/06/01~2007/05/31

專長與研究領域

學門領域
眼科學 (Ophthalmology)
組織工程 (Tissue Engineering)
再生醫學 (Regenerative Medicine)
生醫材料
眼科
醫學工程
學術專長
醫學工程
Medical Engineering
組織工程及再生醫學
組織工程及再生醫學
眼科
Ophthalmology
眼角膜組織工程
眼角膜組織工程
眼角膜細胞學
眼角膜細胞學

論文著作

清冊下載


1. 2024 Wu LH,Cheng YW,Lin FL,Hsu KC,Wang MH,Yen JL, Wang TJ, Lin TE, Liu YC, Huang WJ, Hsiao G.. A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress. . Biomed Pharmacother. .2024

2. 2024 Wang TJ,Rethi L,Ku MY,Nguyen HT,Chuang AE. A review on revolutionizing ophthalmic therapy: Unveiling the potential of chitosan, hyaluronic acid, cellulose, cyclodextrin, and poloxamer in eye disease treatments. . Int J Biol Macromol. .2024

3. 2024 Hsueh CM,Tsai CH,Huang JC,Lee SH,Wang TJ, Guo SP. One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study. . PLoS One .2024

4. 2024 Lin CW,Lin MY,Huang JW,Wang TJ,Lin IC. Impact of dry eye disease treatment on patient quality of life. . Front Med (Lausanne). .2024

5. 2023 Wang TJ,Lin WP,Guo SP. Increased hydrophilicity and anti-fouling effect of orthokeratology lenses coated with NVP and PEGMA by plasma-enhanced chemical vapor deposition. . J Coat Technol Res. .2023 ;(21):737-745

6. 2023 Chien LN,Chou YI,Tsai YJ,Sung LC,Liu HY,Lin MU, Wang TJ, Lin IC. . Association of lipid-lowering agent use and dry eye disease: A nationwide matched case–control study in Taiwan, 2002–2016 . Acta Ophthalmol .2023

7. 2023 Chou YI,Chang HY,Lin MY,Tseng CH,Wang TJ,Lin IC. Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or afibercept injections. . Sci Rep .2023

8. 2022 Hsu SL,Wang TJ. Central Retinal Vein Occlusion Secondary to Bonnet-Dechaume-Blanc Syndrome. . Ophthalmology .2022 ;(129):34-34

9. 2022 Gbetuwa M,Lu LS,Wang TJ,Chen YJ,Chiou JF,Su TY, Yang TS. Nucleus Near-Infrared (nNIR) Irradiation of Single A549 Cells Induces DNA Damage and Activates EGFR Leading to Mitochondrial Fission . Cells .2022 ;(11):624

10. 2022 Rifa W,Wu YW,Delila L,Lee DY,Wang TJ,Burnouf T. In vitro evaluation of platelet extracellular vesicles (PEVs) for corneal endothelial regeneration . Platelets .2022 ;(33):1237-1250

11. 2022 Chang HC,Wang TJ,Lin MH,Chen TJ. A Review of the Systemic Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis . Biomedicines .2022 ;(10):2105

12. 2021 Guo SP,Chang HC,Lu LS,Liu DZ,Wang TJ. Activation of kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2/antioxidant response element pathway by curcumin enhances the anti-oxidative capacity of corneal endothelial cells . Biomedicine & Pharmacotherapy .2021 ;(141):111834

13. 2021 Widyaningrum R,Burnouf T,Nebie O,Delila L,Wang TJ. A purified human platelet pellet lysate rich in neurotrophic factors and antioxidants repairs and protects corneal endothelial cells from oxidative stress . Biomedicine & Pharmacotherapy .2021 ;(142):112046

14. 2020 Lin IC,Wang TJ,Wu CL,Lu DH,Chen YR,Yang KC. Chitosan-cartilage extracellular matrix hybrid scaffold induces chondrogenic differentiation to adipose-derived stem cells . Regen Ther .2020 ;(14):238-244

15. 2020 Kuo CH,Huang YH,Lin WP,Wang TJ,Wang MJ. Micro-patterning of mammalian cells on plasma polymerized polypyrrole thin films. . IEEE Transactions on Plasma Science. .2020 ;(49):2428-2434

16. 2020 Hou AL,Wang SY,Lin WP,Kuo WH,Wang TJ,Wang MJ. Surface Antifouling Modification on Polyethylene Filtration Membranes by Plasma Polymerization . Materials .2020 ;(13):5020-5020

17. 2019 Guo HP,Wang TJ. Low Back Pain Followed by Blurred Vision . Journal of General Internal Medicine .2019

18. 2019 Wang YH,Young TH,Wang TJ. Investigating the effect of chitosan/ polycaprolactone blends in differentiation of corneal endothelial cells and extracellular matrix compositions. . Exp Eye Res .2019 ;(185):107679-107679

19. 2018 Guo HP,Su IC,Wang TJ. Wyburn-Mason syndrome . British Medical Journal .2018 ;(360):k639-k639

20. 2018 Chang SH,Mohammadvali A,Chen KJ,Ji YR,Young TH,Wang TJ. The Relationship Between Mechanical Properties, Ultrastructural Changes, and Intrafibrillar Bond Formation in Corneal UVA/Riboflavin Cross-linking Treatment for Keratoconus. . J Refract Surg .2018 ;(34):264-272

21. 2018 Lin HJ,Wang TJ,Li TW ,Chang YY,Sheu MT,Huang YY, Liu DZ. Development of Decellularized Cornea by Organic Acid Treatment for Corneal Regeneration. . Tissue Eng Part A. .2018 ;(25):652-662

22. 2018 Chen MS,Wang TJ,Lin HC,Thierry B. Four types of human platelet lysate, including one virally inactivated by solvent-detergent, can be used to propagate Wharton Jelly mesenchymal stromal cells. . N Biotechnol .2018 ;(49):151-160

23. 2017 Chen HC,Chen ZY,Wang TJ,Drew VJ,Tseng CL,Fang HW, Lin FH. Herbal Supplement in a Buffer for Dry Eye Syndrome Treatment. . Int J Mol Sci .2017 ;(18):1697

24. 2017 Wang TJ,Chen MS,Chou ML,Lin HC,Seghatchian J,Burnouf T. Comparison of three human platelet lysates used as supplements for in vitro expansion of corneal endothelium cells . Transfusion and Apheresis Science .2017 ;(56):769-773

25. 2016 Fang HW,Li LT,Teng SC,Wang TJ. Application of adipose-derived stem cells to observe the morphological changes by induction with decellularized corneal extracellular matrix and specified medium. . Journal of Medical and Biological Engineering .2016

26. 2016 Guo HP,Wang TJ. Serratia marcescens Panophthalmitis. . The American Journal of the Medical Sciences. .2016

27. 2016 Chen YT,Wang HH,Wang TJ,Li YC,Chen TJ. Early application of low-level laser may reduce the incidence of postherpetic neuralgia (PHN). . J Am Acad Dermatol. .2016 ;(75):572-577

28. 2016 Wang TJ,Wang IJ,Hu FR,Young TH. Applications of biomaterials in corneal endothelial tissue engineering. . Cornea .2016 ;(35):S25-S30

29. 2014 Lin IC,Wang YH,Wang TJ,Wang IJ,Shen YD,Chi NF, Chien LN. Glaucoma, Alzheimer's disease, and Parkinson's disease: an 8-year population-based follow-up study . PLoS One .2014 ;(9):1-6

30. 2014 Ming-Li Chou,Thierry Burnouf,Tsung-Jen Wang. Ex vivo Expansion of Bovine Corneal Endothelial Cells in Xeno-Free Medium Supplemented with Platelet Releasate . PLOS ONE .2014 ;(9):1-8

31. 2014 Young TH,Wang IJ,Hu FR,Wang TJ. Fabrication of a bioengineered corneal endothelial cell sheet usingchitosan/polycaprolactone blend membranes . Colloids Surf B Biointerfaces. .2014 ;(116):403-410

32. 2013 Wang TJ,Ho JD,Lee PY,Lin HC. Association between retinal vein occlusion and conjunctival haemorrhage. . Acta Ophthalmol. .2013 ;(91):e579-e580

33. 2013 Yi-Hsin Chen,Shao-Hsuan Chang,Tsung-Jen Wang,I-Jong Wang,Tai-Horng Young. Cell fractionation on pH-responsive chitosan surface . Biomaterials .2013 ;(34):854-863

34. 2013 Chen YH,Chang SH,Wang TJ,Wang IJ,Young TH. Cell fractionation on pH-sensitive chitosan surface . Biomaterials .2013 ;(34):854-863

35. 2013 Wang TJ,Keller JJ,Sheu JJ,Lin HC. A 3-year follow-up study on the risk of stroke among patients with conjunctival haemorrhage. . Acta Ophthalmol. .2013 ;(91):226-230

36. 2012 Tsung-Jen Wang,Chao-Chien Hu,Herng-Ching Lin. Increased Risk of Uveitis Following Herpes Zoster: A Nationwide Population-based Study. . Arch Ophthalmol .2012 ;(130):451-455

37. 2012 Tsung-Jen Wang,I-Jong Wang,Jui-Nan Lu,Tai-Horng Young. Novel chitosan-polycaprolactone blends as potential scaffold and carrier for corneal endothelial transplantation. . Molecular Vision .2012 ;(2012):255-264

38. 2012 Wang TJ,Wu CK,Hu CC,Keller JJ,Lin HC. Increased Risk of Co-morbid Eye Disease in Patients with Chronic Renal Failure: A Population-based Study. . Ophthalmic Epidemiology .2012 ;(19):137-143

39. 2012 Wang TJ,Wang IJ,Hu CC,Lin HC. Cormorbidities of dry eye disease: a nationwide population-based study . Acta Ophthalmologica .2012 ;(90):663-668

40. 2012 Wang TJ,Lin YH,Chang DC,Chou HC,Wang IJ. Comparison of the effects of cylindrical correction with and without iris recognition technology in wavefront LASIK. . Clin Experiment Ophthalmol. .2012 ;(40):239-246

41. 2012 Chung SD,Hu CC,Ho JD,Keller JJ,Wang TJ,Lin HC. Open-Angle Glaucoma and the Risk of Erectile Dysfunction: A Population-based Case-control Study. . Ophthalmology .2012 ;(119):289-293

42. 2012 Wang TJ,Wang IJ,Chen YH,Lu JN,Young TH. Polyvinylidene fluoride for proliferation and preservation of bovine corneal endothelial cells by enhancing type IV collagen production and deposition. . J Biomed Mater Res A .2012 ;(100):252-260

43. 2012 Wang TJ,Wang IJ,Chen S,Chen YH,Young TH. The phenotypic response of bovine corneal endothelial cells on chitosan/polycaprolactone blends. . Colloids Surf B Biointerfaces. .2012 ;(90):236-243

44. 2011 Chen WL,Shen EP,Hsieh YT,Yeh PT,Wang TJ,Hu FR. Comparison of in vivo confocal microscopic findings between epi-LASIK procedures with different management of the epithelial flaps. . Invest Ophthalmol Vis Sci. .2011 ;(52):3640-3647

45. 2011 Lee PY,Huang MC,Wang TJ. Optic disc combining with an optic nerve cyst- a case report . Taiwan Journal of Ophthalmology .2011

46. 2010 Wang TJ,Wang IJ,Ho JD,Chou HC,Lin SY,Hunag MH. Comparison of the Clinical Effects of Carbomer-Based Lipid-Containing Gel and Hydroxypropyl-Guar Gel Artificial Tear Formulations in Patients with Dry Eye Syndrome: A 4-Week Prospective, Open-Label, Randomized, Parellel-Group, Noninferiority Study . Clinical Therapeutics .2010 ;(32):44-52

47. 2010 Lo W,Wang TJ,Chen WL,Hsueh CM,Chen SJ,Chen YF. Label-free structural characterization of mitomycin C–modulated wound healing after photorefractive keratectomy by the use of multiphoton microscopy . Journal of Biomedical Optics .2010 ;(15):036005-9

48. 2010 Wang TJ,Wang IJ,Hu CC,Lin HC. Comorbidities of dry eye disease: a nationwide population-based study. . Acta Ophthalmol. .2010 ;(Epub):1-6

49. 2009 Wang TJ,Chiang TH,Wang TH,Lin LK,Shih YF. Changes of the ocular refraction among freshmen in National Taiwan University between 1988 and 2005. . Eye .2009 ;(23):1168-9

50. 2008 Shih CW,Yang CM,Chen MS,Wang TJ. Intravitreal injection of bevacizumab and gas for diabetic premacular hemorrhage with active fibrovascular proliferation. . Graefes Arch Clin Exp Ophthalmol. .2008 ;(246):1547-1551

51. 2008 Wang TJ,Lo W,Hsueh CM,Hsieh MS,Dong CY,Hu FR. Ex-Vivo Multiphoton analysis of rabbit corneal wound healing following conductive keratoplasty . Journal of Biomedical Optics .2008 ;(13):034019-9

52. 2007 Wang TJ,Hou YC,Wang IJ,Hu FR. Acute bilateral diffuse corneal opacity in a child. . Cornea .2007 ;(26):375-378

53. 2006 Wang TJ,Chen MS,Yang CM,Ho TC. Subthreshold transpupillary thermotherapy for early resolution of foveal subretinal fluid in choroidal metastasis. . Retina .2006 ;(26):391-395

54. 2006 Wang LC,Wang TJ,Yang CM. Entrapped preretinal oil bubble: report of two cases. . Jpn J Ophthalmol .2006 ;(50):277-279

55. 2005 Wang TJ,Jou JR,Woung LC,Shih YF,Lin LK. Ophthalmic manifestations of intracranial dural arteriovenous fistula. . Tzu-Chi Med J .2005 ;(17):93-97

56. 2005 Wang TJ,Yang CM,HoTC,Huang JS,Yang CH,Chen MS, Lin LL. Metastatic choroidal tumors in Taiwan: an 11-year experience. . Am J Ophthalmol .2005 ;(140):735-737

57. 2005 Wang TJ,Chen MS,Shih YF,Hu WL,Lai MY. Fundus abnormalities in a patient with type I Guacher’s disease with 12-year follow-up. . Am J Ophthalmol .2005 ;(139):359-362

58. 2005 Wang TJ,Wang IJ,Hou YC,Hu FR. Giant epithelial ingrowth induced by blunt injury after automated lamellar keratoplasty. . J Formos Med Assoc. .2005 ;(104):279-281

59. 2005 Wang TJ,Liao SL,Jou JR,Lin LL. Clinical manifestations and management of orbital mucoceles: the role of ophthalmologists. . Jpn J Ophthalmol .2005 ;(49):239-245

60. 2005 Wang TJ,Huang JS,Hsueh PR. Acute postoperative Morganella morganii panophthalmitis. . Eye .2005 ;(19):713-715

研究計畫

計畫名稱
113 血漿衍生的載有薑黃素的血小板囊泡-褐藻醣膠奈米載體的鼻內遞送用於緩解糖尿病視網膜病變(1/3)
補助單位
國家科學及技術委員會

計畫名稱
112 設計兒茶素包覆於血小板衍生細胞外囊泡透過鼻腔至視網膜傳輸系統治療青光眼
補助單位
國家科學及技術委員會

計畫名稱
108 應用生醫材料探討眼角膜內皮細胞之相關研究(2/2)
補助單位
科技部

計畫名稱
107 應用UV誘導化學接枝法改質硬式隱形眼鏡表面之抗污染與生物相容性相關研究
補助單位
臺北醫學大學

計畫名稱
107 應用生醫材料探討眼角膜內皮細胞之相關研究(1/2)
補助單位
科技部

計畫名稱
107 國際醫學研究博士學位學程研究生Rifa W君擬於107年12月14日至12月16日赴南韓首爾參加the 12th Asia-Pacific Vitreo-Retina Society (APVRS) Congress
補助單位

計畫名稱
106 利用真空電漿製備具有羧基及胺基之薄膜應用於大直徑高透氧硬式隱形眼鏡表面改質處理
補助單位
臺北醫學大學

計畫名稱
105 研究分析大直徑高透氧硬式隱形眼鏡於配戴後之特性改變
補助單位
臺北醫學大學

計畫名稱
102 利用幾丁聚醣-聚己內酯混摻生醫材料以培養製作眼角膜內皮細胞層之組織工程研究:實驗,機轉與應用
補助單位
行政院國家科學委員會

計畫名稱
102 利用幾丁聚醣-聚己內酯混摻生醫材料以培養製作眼角膜內皮細胞層之組織工程研究:實驗,機轉與應用
補助單位
科技部

計畫名稱
101 TMU101-AE1-B65
補助單位
附醫

計畫名稱
100 探討角膜內皮細胞於可裂解性生醫材料上行為表現與角膜基質細胞間交互作用之相關研究
補助單位
行政院國家科學委員會

計畫名稱
99 角膜內皮細胞於親疏水程度不同的高分子薄膜上行為表現之相關研究
補助單位
行政院國家科學委員會

計畫名稱
98 利用脂肪衍生幹細胞在體外共同培養系統中誘導分化以表現角膜內皮細胞特異性標記
補助單位
臺北醫學大學

計畫名稱
96 多光子螢光顯微鏡暨二倍頻顯微鏡於角膜傷口癒合之應用
補助單位
臺北醫學大學附設醫院